Protective Effect of Atazanavir Sulphate Against Pulmonary Fibrosis In Vivo and In Vitro.

about

Protective Effect of Atazanavir Sulphate Against Pulmonary Fibrosis In Vivo and In Vitro.

Item

http://www.wikidata.org/entity/Q47799777

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Protective Effect of Atazanavir Sulphate Against Pulmonary Fibrosis In Vivo and In Vitro.

@en

Protective Effect of Atazanavir Sulphate Against Pulmonary Fibrosis In Vivo and In Vitro.

@nl

type

Item

label

Protective Effect of Atazanavir Sulphate Against Pulmonary Fibrosis In Vivo and In Vitro.

@en

Protective Effect of Atazanavir Sulphate Against Pulmonary Fibrosis In Vivo and In Vitro.

@nl

prefLabel

Protective Effect of Atazanavir Sulphate Against Pulmonary Fibrosis In Vivo and In Vitro.

@en

Protective Effect of Atazanavir Sulphate Against Pulmonary Fibrosis In Vivo and In Vitro.

@nl

P1476

Protective Effect of Atazanavir Sulphate Against Pulmonary Fibrosis In Vivo and In Vitro.

@en

P2093

Bin Li

http://www.w3.org/2001/XMLSchema#string

Defang Li

http://www.w3.org/2001/XMLSchema#string

Guanghua Zhang

http://www.w3.org/2001/XMLSchema#string

Shina Song

http://www.w3.org/2001/XMLSchema#string

Wanglin Jiang

http://www.w3.org/2001/XMLSchema#string

Xue Zhang

http://www.w3.org/2001/XMLSchema#string

Yunxia Ji

http://www.w3.org/2001/XMLSchema#string

P2860

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management

A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosis

Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis.

High mobility group box-1 promotes the proliferation and migration of hepatic stellate cells via TLR4-dependent signal pathways of PI3K/Akt and JNK

Gradual increase of high mobility group protein b1 in the lungs after the onset of acute exacerbation of idiopathic pulmonary fibrosis.

Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders

Intestinal Epithelial TLR-4 Activation Is Required for the Development of Acute Lung Injury after Trauma/Hemorrhagic Shock via the Release of HMGB1 from the Gut

TLR9 differentiates rapidly from slowly progressing forms of idiopathic pulmonary fibrosis.

Protective roles of pulmonary rehabilitation mixture in experimental pulmonary fibrosis in vitro and in vivo.

The role of Toll-like receptors in age-associated lung diseases.

P304

199-207

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BCPT.12871

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

122

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28816009

http://www.w3.org/2001/XMLSchema#string

P921

pulmonary fibrosis